# INTERCEPT Safety Evaluation in Anemic Patients

> **NCT03486054** · NA · WITHDRAWN · sponsor: **Swiss Transfusion SRC**

## Conditions studied

- Anemia

## Interventions

- **DEVICE:** INTERCEPT
- **DEVICE:** Standard of Care

## Key facts

- **NCT ID:** NCT03486054
- **Lead sponsor:** Swiss Transfusion SRC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06
- **Primary completion:** 2020-03
- **Final completion:** 2020-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** strategic reasons
- **Last updated:** 2019-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03486054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03486054, "INTERCEPT Safety Evaluation in Anemic Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03486054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*